Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Conference News NY Valves 2025

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Yael L. Maxwell

June 30, 2025

News Conference News PCR London Valves 2024

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Todd Neale

October 26, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News ACC 2023

Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better

Shelley Wood

March 10, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Conference News PCR London Valves 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Conference News PCR London Valves 2022

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

Shelley Wood

December 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2022

Shelley Wood

October 03, 2022

News Conference News TCT 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Yael L. Maxwell

September 26, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Conference News TCT 2021

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Yael L. Maxwell

November 06, 2021

Advertisement

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

What’s Going to Be Big at TCT 2024?

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Debating the Role of T-TEER in the Sickest Patients

Top Structural Heart News of 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

What’s Going to Be Hot at TCT 2023

Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better

Top Structural Heart News of 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

TCTMD’s Top 10 Most Popular Stories for September 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

FDA Approves Pascal TEER Device for Degenerative MR

New Faces, New Formats, New Tech: What to Expect From TCT 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content